Advaxis to Participate in Cervivor School

Kim Dorney to give opening keynote to cervical cancer survivors PRINCETON, N.J., Aug. 19, 2016 (GLOBE NEWSWIRE) — Advaxis, Inc. (NASDAQ:ADXS) a clinical-stage biotechnology company developing cancer immunotherapies, is pleased to participate in Cervivor School...